CD8A and neoplasm: It has been reported that cDC1 is primarily responsible for cross-presenting tumor antigens to naïve CD8+ T cells, generating cytotoxic T lymphocytes (CTLs) [48], whereas cDC2 can present exogenous antigens via MHCII to CD4+ T cells [49,50].